CLS receives market approval for its TRANBERG portfolio by HSA in Singapore and initiates the process of commercialization in the region
Lund, Sweden – Clinical Laserthermia Systems AB (publ) (CLS) today announces that the company has received market approval for its entire portfolio of TRANBERG® Thermal Therapy products in Singapore for thermal ablation of soft tissue pathological lesions for tumor control, symptomatic relief and restoring of physiological functions in the prostate and liver.The market approval for CLS portfolio of TRANBERG Thermal Therapy Systems by HSA in Singapore constitutes a significant milestone in the company’s global expansion and enables CLS to initiate the process of commercialization throughout